Literature DB >> 1869061

Intraocular pressure response to the replacement of pilocarpine or carbachol with echothiophate.

R W Reichert1, M B Shields.   

Abstract

In 20 patients with open-angle glaucoma in aphakia or pseudophakia whose intraocular pressure had remained uncontrolled on their current medical therapy, the medication was changed from pilocarpine or carbachol to echothiophate iodide. In all, 12 patients (60%) showed a statistically significant improvement in pressure control, 7 (35%) showed no change, and 1 had higher pressure. One-third of the patients with improved intraocular-pressure control eventually required laser or incisional surgery after a mean of 23 months, whereas the remaining subjects were controlled for the duration of the follow-up, which averaged 26 months. Side effects encountered during echothiophate iodide treatment included ocular irritation, decreased vision, and one retinal detachment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1869061     DOI: 10.1007/bf00167878

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  6 in total

Review 1.  Miotics and retinal detachment: a survey and case report.

Authors:  J J Alpar
Journal:  Ann Ophthalmol       Date:  1979-03

2.  Comparison of pilocarpine and echothiophate iodide in open-angle glaucoma.

Authors:  L S Harris
Journal:  Ann Ophthalmol       Date:  1972-09

3.  Dose-response analysis of echothiophate iodide.

Authors:  L S Harris
Journal:  Arch Ophthalmol       Date:  1971-11

4.  Intraocular pressure response to replacing pilocarpine with carbachol.

Authors:  R W Reichert; M B Shields; W C Stewart
Journal:  Am J Ophthalmol       Date:  1988-12-15       Impact factor: 5.258

5.  Retinal detachments and topical ocular miotics.

Authors:  H Beasley; F T Fraunfelder
Journal:  Ophthalmology       Date:  1979-01       Impact factor: 12.079

6.  Retinal detachment and miotic therapy.

Authors:  L G Pape; M Forbes
Journal:  Am J Ophthalmol       Date:  1978-04       Impact factor: 5.258

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.